Related Experiment Video
Updated: Jun 27, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Lepromatous neuropathy
1From the *Department of Medicine/Neurology, University of Texas health Sciences at San Antoins,and the daggerDepartment of Neurology Brigham and Women's Hospital, Boston, MA.
Abstract:
Leprosy still remains a major cause of peripheral neuropathy, particularly in Asia, Africa, and immigrants from these endemic regions of the world. Lepromatous neuropathy can manifest as mononeuropathies, mononeuropachy multiplex, or as a generalized sensorimotor polyneuropathy. The electrophysiologic studies reveal a primarily axoral process, although there may be demyeltnating features as well. Long-term treatment with dapsone, rifampin, and clofazimine is required, A potential complication of therapy, particularly in the borderline patient, is the reversal reaction, a condition caused by upregulation of the cellular immune response. In this condition, patients may develop an exacerbation of their skin lesions and neuropathy, Because lepromatous neuropathy is not rare, neurologists need to be aware of the complex nature of the clinical manifestations, pathogenesis, and treatment of leprosy.
Related Concept Videos
Diabetic Neuropathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Leishmaniasis
Multiple Sclerosis l: Introduction